LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.1400
0.00 (0.00%)
At close: Apr 1, 2026
LianBio Market Cap
LianBio has a market cap or net worth of $15.14 million as of April 2, 2026. Its market cap has decreased by -53.33% in one year.
Market Cap
15.14M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 15.14M, a decrease of -98.95%. That is a compound annual growth rate of -64.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 15.14M | 47.37% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 22.79M |
| Provectus Biopharmaceuticals | 22.09M |
| Inhibitor Therapeutics | 21.36M |
| Zenith Capital | 20.77M |
| ZIVO Bioscience | 20.61M |
| EOM Pharmaceuticals Holdings | 20.11M |
| Oncotelic Therapeutics | 17.43M |
| Zeo ScientifiX | 16.41M |